Daily as of 3 Nov 16:00 ET
- Price
- below both $0.73 vs 50 $0.84 / 200 $1.14
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 10 Nov 2025 · projected 10 bars out
AKBA | Akebia TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$0.73
+$0.02 (+2.46%)
Akebia Therapeutics (AKBA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat below the 200 on the daily since Nov 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $0.71 vs 50 $1.20 / 200 $1.56
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 24 Aug 2026 · projected 30 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- below both $0.72 vs 50 $0.75 / 200 $0.99
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 13 Aug 2026 · projected 13 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| week of 24 Aug 2026 | 💀Death steep | weekly | 30 bars out | Not tested |
| 13 Aug 2026 | 💀Death | 4-hour | 13 bars out | Not tested |
| 27 Jul 2026 | 🟨Golden | 4-hour | 29 bars out | 7 bar cross test |
| 7 May 2026 | 💀Death | 4-hour | not projected | Not tested |
| 6 May 2026 | 🟨Golden | 4-hour | 14 bars out | Not tested |
About AKBA
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmicro